金吾财讯 | 诺和诺德(NVO)盘前股价反弹回升,暂涨4.48%,报88.81美元。该股上周五股价大跌近18%,消息面上,美国食品药品管理局(FDA)批准诺和诺德Alhemo(concizumab)用于治疗12岁及以上的血友病(hemophilia)患者。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.